Apoptosis regulators as targets for cancer therapy

Clinical and Translational Oncology

Volumn 9, Issue 9, 2007, Pages 555-562

  Fernandez Luna J L ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Apoptosis; Bcl 2; Caspases; Therapy; TRAIL; XIAP

Indexed keywords

4 [4 (4' CHLORO 2 BIPHENYLYLMETHYL) 1 PIPERAZINYL] N [4 [3 DIMETHYLAMINO 1 (PHENYLTHIOMETHYL)PROPYLAMINO] 3 NITROBENZENESULFONYL]BENZAMIDE; ANTIMYCIN A1; BH3 PROTEIN; CASPASE; FAS ASSOCIATED DEATH DOMAIN PROTEIN; GAMBOGIC ACID; GOSSYPOL; INHIBITOR OF APOPTOSIS PROTEIN; MAPATUMUMAB; MONOCLONAL ANTIBODY; OBATOCLAX; OBLIMERSEN; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; TEMOZOLOMIDE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR; APOPTOSIS REGULATORY PROTEIN; X LINKED INHIBITOR OF APOPTOSIS;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CARCINOGENESIS; CLINICAL TRIAL; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG SCREENING; DRUG TARGETING; DRUG TREATMENT FAILURE; FOLLICULAR LYMPHOMA; GLIOBLASTOMA; HUMAN; LUNG SMALL CELL CANCER; MELANOMA; MOLECULAR MECHANICS; NONHUMAN; PROSTATE CANCER; PROTEIN FUNCTION; REVIEW; UNSPECIFIED SIDE EFFECT; ANIMAL; BIOLOGICAL MODEL; DRUG ANTAGONISM; METABOLISM; NEOPLASM;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASPASES; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; TNF-RELATED APOPTOSIS-INDUCING LIGAND; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 38449096211     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-007-0103-7     Document Type: Review

References (55)

1. Meier P, Finch A, Evan G (2000) Apoptosis in development. Nature 407:796-801
2. Hutchins JB, Barger SW (1998) Why neurons die: Cell death in the nervous system. Anat Rec 253:79-90
3. Fadeel B, Orrenius S, Zhivotovsky B (1999) Apoptosis in human disease: A new skin for the old ceremony? Biochem Biophys Res Commun 266:699-717
4. Saraste A, Pulkki K (2000) Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res 45:528-537
5. Hengartner MO, Horvitz HR (1994) The ins and outs of programmed cell death during C. elegans development. Philos Trans R Soc Lond B Biol Sci 345:243-246
6. Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239-257
7. Vaux DL, Cory S, Adams JM (1988) Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440-442
8. Reed JC, Cuddy M, Slabiak T et al (1988) Oncogenic potential of bcl-2 demonstrated by gene transfer. Nature 336:259-261
9. McDonnell TJ, Deane N, Platt FM et al (1989) bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 57:79-88
10. Yuan J, Shaham S, Ledoux S et al (1993) The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 75:641-652
11. Liu X, Kim CN, Yang J et al (1996) Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c. Cell 86:147-157
12. Inohara N, Ding L, Chen S et al (1997) harakiri, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival-promoting proteins Bcl-2 and Bcl-X(L). EMBO J 16:1686-1694
13. Yang E, Zha J, Jockel J et al (1995) Bad, a het-erodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell 80:285-291
14. Wang K, Yin XM, Chao DT et al (1996) BID: A novel BH3 domain-only death agonist. Genes Dev 10:2859-2869
15. Yin XM, Wang K, Gross A et al (1999) Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature 400:886-891
16. Bouillet P, Metcalf D, Huang DC et al (1999) Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286:1735-1738
17. Uren AG, Pakusch M, Hawkins CJ et al (1996) Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors. Proc Natl Acad Sci U S A 93: 4974-4978
18. Duckett CS, Nava VE, Gedrich RW et al (1996) A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors. EMBO J 15:2685-2694
19. Muchmore SW, Sattler M, Liang H et al (1996) X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 381:335-341
20. Wang JL, Liu D, Zhang ZJ et al (2000) Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells. Proc Natl Acad Sci U S A 97:7124-7129
21. Oltersdorf T, Elmore SW, Shoemaker AR et al (2005) An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435:677-681
22. Letai A, Bassik MC, Walensky LD et al (2002) Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2:183-192
23. Willis SN, Chen L, Dewson G et al (2005) Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev 19:1294-1305
24. Kim H, Rafiuddin-Shah M, Tu HC et al (2006) Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies. Nat Cell Biol 8:1348-1358
25. Nunez G, Benedict M, Hu Y et al (1998) Caspases: The proteases of the apoptotic pathway. Oncogene 17:3237-3245
26. Morishima N, Nakanishi K, Takenouchi H et al (2002) An endoplasmic reticulum stress-specific caspase cascade in apoptosis. Cytochrome c-independent activation of caspase-9 by caspase-12. J Biol Chem 277:34287-34294
27. Boatright KM, Renatus M, Scott FL et al (2003) A unified model for apical caspase activation. Mol Cell 11:529-541
28. Pop C, Timmer J, Sperandio S et al (2006) The apoptosome activates caspase-9 by dimerization. Mol Cell 22:269-275
29. Vaux DL, Silke J (2005) IAPs, RINGs and ubiquitylation. Nat Rev Mol Cell Biol 6:287-297
30. Gelinas C, White E (2005) BH3-only proteins in control: Specificity regulates MCL-1 and BAK-mediated apoptosis. Genes Dev 19:1263-1268
31. Bredesen DE, Rao RV, Mehlen P (2006) Cell death in the nervous system. Nature 443:796-802
32. Imaizumi K, Benito A, Kiryu-Seo S et al (2004) Critical role for DP5/ Harakiri, a Bcl-2 homology domain 3-only Bcl-2 family member, in axotomy-induced neuronal cell death. J Neurosci 24:3721-3725
33. Coultas L, Bouillet P, Stanley EG et al (2004) Proapoptotic BH3-only Bcl-2 family member Bik/Blk/Nbk is expressed in hemopoietic and endothelial cells but is redundant for their programmed death. Mol Cell Biol 24:1570-1581
34. Zinkel SS, Ong CC, Ferguson DO et al (2003) Proapoptotic BID is required for myeloid homeostasis and tumor suppression. Genes Dev 17:229-239
35. Ranger AM, Zha J, Harada H et al (2003) Bad-deficient mice develop diffuse large B cell lymphoma. Proc Natl Acad Sci U S A 100:9324-9329
36. Villunger A, Michalak EM, Coultas L et al (2003) p53-and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 302:1036-1038
37. Tagawa H, Karnan S, Suzuki R et al (2005) Genome-wide array-based CGH for mantle cell lymphoma: Identification of homozygous deletions of the proapoptotic gene BIM. Oncogene 24:1348-1358
38. Mestre-Escorihuela C, Rubio-Moscardo F, Richter JA et al (2007) Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas. Blood 109:271-280
39. Puthalakath H, Strasser A (2002) Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins. Cell Death Differ 9:505-512
40. Sanz C, Mellstrom B, Link W et al (2001) Interleukin 3-dependent activation of DREAM is involved in transcriptional silencing of the apoptotic Hrk gene in hematopoietic progenitor cells. EMBO J 20:2286-2292
41. Klasa RJ, Gillum AM, Klem RE et al (2002) Oblimersen Bcl-2 antisense: facilitating apoptosis in anticancer treatment. Antisense Nucleic Acid Drug Dev 12:193-213
42. Reed JC (2006) Drug insight: Cancer therapy strategies based on restoration of endogenous cell death mechanisms. Nat Clin Pract Oncol 3:388-398
43. Tzung SP, Kim KM, Basanez G et al (2001) Antimycin A mimics a cell-death-inducing Bcl-2 homology domains 3. Nat Cell Biol 3:183-191
44. Real PJ, Cao Y, Wang R et al (2004) Breast cancer cells can evade apoptosis-mediated selective killing by a novel small molecule inhibitor of Bcl-2. Cancer Res 64:7947-7953
45. Kitada S, Leone M, Sareth S et al (2003) Discovery, characterization, and structure-activity relationships studies of proapoptotic polyphenols targeting B-cell lymphocyte/leukemia-2 proteins. J Med Chem 46:4259-4264
46. Trauth BC, Klas C, Peters AM et al (1989) Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301-305
47. Cretney E, Takeda K, Yagita H et al (2002) Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing lig-and-deficient mice. J Immunol 168:1356-1361
48. Walczak H, Miller RE, Ariail K et al (1999) Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5:157-163
49. Hao C, Song JH, Hsi B et al (2004) TRAIL inhibits tumor growth but is nontoxic to human hepatocytes in chimeric mice. Cancer Res 64:8502-8506
50. Tolcher AW, Mita M, Meropol NJ et al (2007) Phase I pharmacokinetic and biologic correlative study of mapatumumab, a fully human monoclonal antibody with agonist activity to tumor necrosis factor-related apoptosis-inducing ligand receptor-1. J Clin Oncol 25:1390-1395
51. Schimmer AD, Welsh K, Pinilla C et al (2004) Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity. Cancer Cell 5:25-35
52. Li L, Thomas RM, Suzuki H et al (2004) A small molecule Smac mimic potentiates TRAIL-and TNFalpha-mediated cell death. Science 305:1471-1474
53. Jiang X, Kim HE, Shu H et al (2003) Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway. Science 299:223-226
54. Zhang HZ, Kasibhatla S, Wang Y et al (2004) Discovery, characterization and SAR of gambogic acid as a potent apoptosis inducer by a HTS assay. Bioorg Med Chem 12:309-317
55. Putt KS, Chen GW, Pearson JM et al (2006) Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy. Nat Chem Biol 2:543-550